Frontier IP investee partners with Chinese biotech firm
(Sharecast News) - Frontier IP's portfolio company Exscientia on Friday expanded its presence in Asia after it entered an AI drug discovery partnership with Shanghai-headquartered GT Apeiron Therapeutics.
Read more